Press Releases
WASHINGTON – U.S. Reps. Diana DeGette (CO-01) and Louise Slaughter (NY-25), co-chairs of the House Pro-Choice Caucus, issued the following statement after the U.S. Supreme Court released its decision in McCullen v. Coakley, which affirms the legality of buffer zones outside of healthcare facilities while striking down Massachusetts' 35-foot fixed buffer zone law over specific issues:
WASHINGTON – Today, U.S Rep. Diana DeGette (CO-01) issued the following statement after the 10th Circuit Court of Appeals in Denver, Colorado ruled that Utah's ban on same-sex marriage is unconstitutional:
WASHINGTON – U.S. Reps. Diana DeGette (CO-01) and Louise Slaughter (NY-25), the co-chairs of the House Pro-Choice Caucus, issued the following statement after the House Appropriations Committee passed an amendment to permit Peace Corps volunteers to receive abortion coverage in cases of case of rape, incest or when the life of the mother is at stake:
WASHINGTON – Today, U.S. Rep. Diana DeGette (CO-01) and Energy and Commerce Committee Chairman Fred Upton (MI-06) hosted a roundtable discussion with leading experts in the field of digital health care as part of the bipartisan 21st Century Cures initiative.
WASHINGTON – U.S. Rep. Diana DeGette (CO-01) urged Iraq and Afghanistan veterans to sign up for the Veterans Affairs Airborne Hazards and Open Burn Pit Registry, which is now available online.
WASHINGTON — Today Ranking Members Diana DeGette and Henry A. Waxman sent a letter to Chairmen Fred Upton and Tim Murphy to request hearings on the implications to seniors, taxpayers, Part D drug plans, and the Medicare program of the high costs of Sovaldi, the new Hepatitis C drug manufactured by Gilead Pharmaceuticals.
DENVER – Today, U.S. Rep. Diana DeGette (CO-01) issued the following statement in response to President Obama's announcement of an executive order banning discrimination by federal contractors on the basis of sexual orientation or gender identity.
WASHINGTON – Today, U.S. Rep. Diana DeGette (CO-01) called for new approaches to encourage further investments in drug innovation. The hearing on "21st Century Cures: Examining the role of Incentives in Advancing Treatments and Cures for Patients" was conducted in the Energy and Commerce Subcommittee on Health.
WASHINGTON, DC— Today Ranking Member Henry A. Waxman and Oversight and Investigations Subcommittee Ranking Member Diana DeGette sent a letter to Chairmen Fred Upton and Tim Murphy requesting a hearing on recent findings from the U.S. Chemical Safety and Hazard Investigation Board (CSB).
DENVER – Today, U.S. Rep. Diana DeGette (CO-01) announced that young Coloradoans previously enrolled in the Deferred Action for Childhood Arrivals (DACA) program can now renew their status for an additional two-year period.